脓毒症预后相关生物标志物的研究进展
Advances in the Study of Prognosis-Related Biomarkers in Sepsis
DOI: 10.12677/ACM.2023.1392072, PDF,   
作者: 屈峻杰：新疆医科大学研究生院，新疆 乌鲁木齐；石晓卉：新疆维吾尔自治区人民医院重症医学科，新疆 乌鲁木齐
关键词: 脓毒症；生物标志物；预后；Sepsis； Biomarkers； Prognosis
摘要: 脓毒症是人体对感染的免疫反应失调而导致的全身多脏器功能障碍，在重症监护住院患者中具有高发病率、高死亡率等特点。因此早期评估脓毒症患者预后并及时干预治疗对降低患者死亡率、减少患者住院时间及住院费用等具有重要意义。近年来，寻找简单、可靠的早期生物标志物，早期评估脓毒症患者不良预后，是目前临床中关注的热点问题之一，该文就近年用于评估脓毒症患者预后的生物标志物的研究进展进行综述。
Abstract: Sepsis is a systemic multiple organ dysfunction caused by the imbalance of immune response to in-fection. Sepsis has the characteristics of high morbidity and mortality in intensive care inpatients. Therefore, early evaluation of the prognosis of patients with sepsis and timely intervention treat-ment is of great significance to reduce mortality, hospitalization time and hospitalization costs. At present, there are many biomarkers that can be used to evaluate the prognosis of patients with sepsis, and these biomarkers have their own advantages in clinical application. This paper reviews the research progress of biomarkers used to evaluate the prognosis of patients with sepsis in recent years.
文章引用：屈峻杰, 石晓卉. 脓毒症预后相关生物标志物的研究进展[J]. 临床医学进展, 2023, 13(9): 14810-14817. https://doi.org/10.12677/ACM.2023.1392072

参考文献

[1] Singer, M., Deutschman, C.S., Seymour, C.W., et al. (2016) The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA, 315, 801-810. [Google Scholar] [CrossRef] [PubMed]
[2] Fleischmann-Struzek, C., Mellhammar, L., Rose, N., et al. (2020) In-cidence and Mortality of Hospital- and ICU-Treated Sepsis: Results from an Updated and Expanded Systematic Review and Meta-Analysis. Intensive Care Medicine, 46, 1552-1562. [Google Scholar] [CrossRef] [PubMed]
[3] Velly, L., Volant, S., Fitting, C., et al. (2021) Optimal Combina-tion of Early Biomarkers for Infection and Sepsis Diagnosis in the Emergency Department: The BIPS Study. Journal of Infection, 82, 11-21. [Google Scholar] [CrossRef] [PubMed]
[4] 商蕾, 杨靖娴, 刘雪凯. 电解质检测对血培养阳性脓毒症患者转归的影响[J]. 实用检验医师杂志, 2022, 14(3): 303-306.
[5] Bartoletti, M., Antonelli, M., Blasi, F.A.B., et al. (2018) Procalcitonin-Guided Antibiotic Therapy: An Expert Consensus. Clinical Chemistry and Laboratory Medicine, 56, 1223-1229. [Google Scholar] [CrossRef] [PubMed]
[6] Eschborn, S. and Weitkamp, J.-H. (2019) Procalci-tonin versus C-Reactive Protein: Review of Kinetics and Performance for Diagnosis of Neonatal Sepsis. Journal of Per-inatology, 39, 893-903. [Google Scholar] [CrossRef] [PubMed]
[7] Demirdal, T., Sen, P. and Nemli, S.A. (2018) Diagnostic Value of Procalcitonin in Predicting Bacteremia in Intensive Care Unit. Indian Journal of Critical Care Medicine, 22, 78-84. [Google Scholar] [CrossRef] 
[8] Durrance, R.J., Ullah, T., Patel, H., et al. (2020) Marked Eleva-tion in Serum Procalcitonin Levels Do Not Correlate with Severity of Disease or Mortality in Hospitalized Patients: A Retrospective Study. Biomarker Insights, 15. [Google Scholar] [CrossRef] [PubMed]
[9] 张权, 刘泽鹏, 冯建宏, 李彩霞. 血清降钙素原及其动态变化对于脓毒症病情严重程度的评估价值[J]. 西部医学, 2023, 35(4): 543-547.
[10] Shen, Y., Huang, X. and Zhang, W. (2019) Platelet-to-Lymphocyte Ratio as a Prognostic Predictor of Mortality for Sepsis: Interaction Effect with Disease Severity—A Retrospective Study. BMJ Open, 9, e22896. [Google Scholar] [CrossRef] [PubMed]
[11] Thorup, C.V., Christensen, S. and Hvas, A.-M. (2020) Imma-ture Platelets as a Predictor of Disease Severity and Mortality in Sepsis and Septic Shock: A Systematic Review. Semi-nars in Thrombosis and Hemostasis, 46, 320-327. [Google Scholar] [CrossRef] [PubMed]
[12] Drewry, A.M., Samra, N., Skrupky, L.P., et al. (2014) Persistent Lymphopenia after Diagnosis of Sepsis Predicts Mortality. Shock, 42, 383-391. [Google Scholar] [CrossRef] 
[13] Zheng, R., Shi, Y.-Y., Pan, J.-Y. and Qian, S.-Z. (2023) Decrease in the Platelet-to-Lymphocyte Ratio in Days after Admission for Sepsis Correlates with in-Hospital Mortality. Shock, 59, 553-559. [Google Scholar] [CrossRef] 
[14] 张小彬, 刘丹, 闫晶, 等. 中性粒细胞与淋巴细胞比值和血小板与淋巴细胞比值评估脓毒症患者预后的价值[J]. 宁夏医科大学学报, 2020, 42(4): 367-371.
[15] Polilli, E., Frattari, A., Esposito, J.E., et al. (2021) Monocyte Distribution Width (MDW) as a New Tool for the Prediction of Sepsis in Critically Ill Patients: A Preliminary Investigation in an Intensive Care Unit. BMC Emergency Medicine, 21, Ar-ticle No. 147. [Google Scholar] [CrossRef] [PubMed]
[16] Agnello, L., Sasso, B.L., Vidali, M., et al. (2021) Validation of Monocyte Distribution Width Decisional Cutoff for Sepsis Detection in the Acute Setting. International Journal of Laboratory Hematology, 43, O183-O185. [Google Scholar] [CrossRef] [PubMed]
[17] Crouser, E.D., Parrillo, J.E., Seymour, C., et al. (2017) Improved Early De-tection of Sepsis in the ED with a Novel Monocyte Distribution Width Biomarker. CHEST, 152, 518-526. [Google Scholar] [CrossRef] [PubMed]
[18] Oude Lansink-Hartgring, A., Hessels, L., Weigel, J., et al. (2016) Long-Term Changes in Dysnatremia Incidence in the ICU: A Shift from Hyponatremia to Hypernatremia. Annals of In-tensive Care, 6, Article No. 22. [Google Scholar] [CrossRef] [PubMed]
[19] Shirazy, M., Omar, I., Abduljabbar, D., et al. (2020) Prevalence and Prognostic Impact of Hypernatremia in Sepsis and Septic Shock Patients in the Intensive Care Unit: A Single Centre Experience. The Journal of Critical Care Medicine, 6, 52-58. [Google Scholar] [CrossRef] [PubMed]
[20] Lin, C.-Y., Chen, Y.-M., Tsai, Y.-H., et al. (2022) Association of Hypernatremia with Immune Profiles and Clinical Out-comes in Adult Intensive Care Unit Patients with Sepsis. Biomedicines, 10, Article No. 2285. [Google Scholar] [CrossRef] [PubMed]
[21] Ni, H.-B., Hu, X.-X., Huang, X.-F., et al. (2016) Risk Factors and Outcomes in Patients with Hypernatremia and Sepsis. The American Journal of the Medical Sciences, 351, 601-605. [Google Scholar] [CrossRef] [PubMed]
[22] Bravo-Sagua, R., Parra, V., López-Crisosto, C., et al. (2017) Calcium Transport and Signaling in Mitochondria. In: R. Terjung, R., Ed., Comprehensive Physiology, Vol. 7, American Physiological Society, Rockville, 623-634. [Google Scholar] [CrossRef] [PubMed]
[23] Iqbal, M., Rehmani, R., Hijazi, M., Abdulaziz, A. and Kashif, S. (2008) Hypocalcemia in a Saudi Intensive Care Unit. Annals of Thoracic Medicine, 3, 57-59. [Google Scholar] [CrossRef] [PubMed]
[24] 费明明, 李平, 陶小根, 等. 血钙水平对脓毒症患者预后的影响[J]. 中华危重病急救医学, 2019, 31(4): 418-421.
[25] Fernández, R., Cortés, P., Del Rio, R., Acuña-Castillo, C. and Reyes, E.P. (2015) Lipopolysaccharide-Induced Ionized Hypocalcemia and Acute Kidney Injury in Carotid Chemo/Baro-Denervated Rats. In: Peers, C., Kumar, P., Wyatt, C., Gauda, E., Nurse, C. and Prabhakar, N., Eds., Arteri-al Chemoreceptors in Physiology and Pathophysiology. Advances in Experimental Medicine and Biology, Vol. 860, Springer, Cham, 161-166. [Google Scholar] [CrossRef] [PubMed]
[26] 游婷婷. 脓毒症患者离子钙水平及危险因素分析[J]. 福建医药杂志, 2018, 40(1): 14-18.
[27] 朱永, 麦叶, 吴远怡, 等. 甲状旁腺激素及血清钙水平与脓毒症患者病情严重程度和预后的关系[J]. 现代生物医学进展, 2015, 15(17): 3319-3321.
[28] Manvitha, G., Rampure, D.M. and Bandarupalli, S. (2020) Hypomagnesemia in Critically Ill Medical Patients—A Prognostic Indicator. Journal of the Asso-ciation of Physicians of India, 68, 88.
[29] 童飞, 房晓伟, 朱春艳, 潘爱军. 低镁血症对重症脓毒症患者预后的影响[J]. 中华危重病急救医学, 2022, 34(1): 23-27.
[30] Thongprayoon, C., Cheungpasitporn, W. and Erickson, S.B. (2015) Admission Hypomagnesemia Linked to Septic Shock in Patients with Systemic Inflammatory Response Syn-drome. Renal Failure, 37, 1518-1521. [Google Scholar] [CrossRef] 
[31] Liu, X.-W., Ma, T., Liu, W., et al. (2018) Sustained Increase in Angiopoietin-2, Heparin-Binding Protein, and Procalcitonin is Associated with Severe Sepsis. Journal of Critical Care, 45, 14-19. [Google Scholar] [CrossRef] [PubMed]
[32] Dou, Q.-L., Liu, J., Zhang, W., et al. (2022) Dynamic Changes in Heparin-Binding Protein as a Prognostic Biomarker for 30-Day Mortality in Sepsis Patients in the Intensive Care Unit. Scientific Reports, 12, Article No. 10751. [Google Scholar] [CrossRef] [PubMed]
[33] Katsaros, K., Renieris, G., Safarika, A., et al. (2022) Heparin Binding Protein for the Early Diagnosis and Prognosis of Sepsis in the Emergency Department: The Prompt Multicenter Study. Shock, 57, 518-525. [Google Scholar] [CrossRef] 
[34] Zhang, J.-L., Chen, Y.-T., Chen, G.-D., et al. (2017) Glu-cose-Insulin-Potassium Alleviates Intestinal Mucosal Barrier Injuries Involving Decreased Expression of Uncoupling Protein 2 and NLR Family-Pyrin Domain-Containing 3 Inflammasome in Polymicrobial Sepsis. BioMed Research Inter-national, 2017, Article ID: 4702067. [Google Scholar] [CrossRef] [PubMed]
[35] Huang, W., Wang, X., Zhang, H., Wang, C. and Liu, D. (2020) The Value of Serum Uncoupling Protein-2 Level for the Patients with Sepsis. Shock, 54, 301-307. [Google Scholar] [CrossRef] 
[36] 谢正应, 周新华, 王娟. 血清解偶联蛋白2在脓毒症及脓毒性休克中的表达及其临床意义[J]. 中国急救医学, 2021, 41(9): 803-807.
[37] 崔晓萌, 陈慧勇, 丁振奇, 等. 血清淀粉样蛋白A (SAA)升高的大动脉炎(TA)患者免疫炎症状态[J]. 复旦学报(医学版), 2018, 45(6): 793-798.
[38] 曹琳, 宋晓文, 任金来, 宿振国. 血清淀粉样蛋白A的研究进展[J]. 安徽医药, 2019, 23(2): 221-224.
[39] 徐挺立, 李丽芳, 徐天阳, 潘玲玲. 血清淀粉样蛋白A、诱骗受体3与脓毒症病情严重程度及预后的关系[J]. 浙江实用医学, 2020, 25(1): 27-30.
[40] 牛凯旋, 吴淑璐, 刘成, 邓晰明. 血清淀粉样蛋白A和白细胞介素-6对脓毒症诊断及病情严重程度评估的临床价值[J]. 中华全科医学, 2022, 20(9): 1484-1487.

为你推荐